LUNG TRANSPLANTATION
Clinical trials for LUNG TRANSPLANTATION explained in plain language.
Never miss a new study
Get alerted when new LUNG TRANSPLANTATION trials appear
Sign up with your email to follow new studies for LUNG TRANSPLANTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug aimed at stopping lung rejection in transplant patients
Disease control Not yet recruitingThis early-stage trial tests a drug called fostamatinib in 30 adults who have developed donor-specific antibodies after a lung transplant. These antibodies can attack the new lung and raise the risk of death. Participants take fostamatinib or a placebo for 8 weeks, along with the…
Matched conditions: LUNG TRANSPLANTATION
Phase: PHASE1 • Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Disease control
Last updated Jul 02, 2026 01:00 UTC
-
New pain block could cut opioid use after lung transplants
Symptom relief Not yet recruitingThis study tests whether a long-acting form of the numbing drug bupivacaine (liposomal bupivacaine) can reduce pain and the need for strong opioid painkillers after lung transplant surgery. 88 adults receiving a double lung transplant will get an intercostal nerve block either wi…
Matched conditions: LUNG TRANSPLANTATION
Phase: PHASE4 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Symptom relief
Last updated Jun 27, 2026 13:07 UTC